The impact of fungal endophthalmitis

Article

A great variety of fungal agents may cause endophthalmitis, and accurate diagnosis is essential for effective treatment, according to a study published in the November/December 2008 issue of Retina.

A great variety of fungal agents may cause endophthalmitis, and accurate diagnosis is essential for effective treatment, according to a study published in the November/December 2008 issue of Retina.

Arunaloke Chakrabarti, MD of the Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh, India and colleagues conducted a retrospective review of all cases (n=113) of fungal endophthalmitis diagnosed in a single tertiary care centre between January 1992 and December 2005.

The researchers found that fungal endophthalmitis developed for the following reasons: after cataract surgery (n=53), after trauma (n=48) or endogenous (n=12). The fungi causing the infections were identified as: aspergillus, 54.4% (of which, Aspergillus flavus accounted for 24.6%); yeasts, 24.6% (of which, Candida tropicalis accounted for 8.8%); melanized fungi, 10.5%; other isolated fungal agents, including Fonsecaea pedrosoi, Pseudallescheria boydii and Trichosporon cutaneum. Patients were treated with pars plana vitrectomy, intravitreal amphotericin B 5 µg and dexamethasone 400 µg, and, in some cases, oral fluconazole (n=27) or itraconazole (n=78). Treatment outcomes were unfavourable for 77.4% of patients infected with aspergillus; for 64.3% of patients infected with yeasts; for 50.0% of patients infected with melanized fungi; for 16.7% of patients infected with mycelial fungi; for 52.8% of patients whose endophthalmitis developed following cataract surgery; for 66.7% of patients who developed endophthalmitis following trauma, and for 33.3% of patients with endogenous endophthalmitis.

From these data, Dr Chakrabarti and colleagues concluded that, although aspergillus is the most common cause of fungal endophthalmitis, there are many other fungal agents that may cause this disease. The team considered that diagnosing endophthalmitis as fungal in origin presents a significant challenge to doctors.

Recent Videos
Patrick C. Staropoli, MD, discusses clinical characterisation of Hexokinase 1 (HK1) mutations causing autosomal dominant pericentral retinitis pigmentosa
Richard B. Rosen, MD, discusses his ASRS presentation on illuminating subclinical sickle cell activities using dynamic OCT angiography
ASRS 2024: Socioeconomic barriers and visual outcomes in patients with rhegmatogenous retinal detachments, from Sally S. Ong, MD
Ashkan Abbey, MD, speaks about his presentation on the the CALM registry study, the 36-month outcomes of real world patients receiving fluocinolone acetonide 0.18 mg at the annual ASRS meeting in Stockholm, Sweden.
Nikoloz Labauri, MD, FVRS, speaks at the 2024 ASRS meeting about suspensory macular buckling as a novel technique for addressing myopic traction maculopathy
Jordana Fein, MD, MS, speaks with Modern Retina about the IOP outcomes with aflibercept 8 mg and 2 mg in patients with DME through week 48 of the phase 2/3 PHOTON trial at the annual ASRS meeting in Stockholm, Sweden.
John T. Thompson, MD, discusses his presentation at ASRS, Long-Term Results of Macular Hole Surgery With Long-Acting Gas Tamponade and Internal Limiting Membrane Peeling
ASRS 2024: Michael Singer, MD, shares 100-week results from the RESTORE trial
© 2024 MJH Life Sciences

All rights reserved.